Results
eNauka >
Rezultati >
Final results from a phase III trial evaluating panitumumab (pmab) plus best supportive care (BSC) vs BSC in chemorefractory wild-type (WT) KRAS exon 2 and WT RAS metastatic colorectal cancer (mCRC).
| Naziv: | Final results from a phase III trial evaluating panitumumab (pmab) plus best supportive care (BSC) vs BSC in chemorefractory wild-type (WT) KRAS exon 2 and WT RAS metastatic colorectal cancer (mCRC). | Autori  : | Kim, Tae Won; ...; Kusic, Zvonko; ...; Manojlović, Nebojša S.   ; ...; (broj, koautora 16) |
Godina: | 2016 | Publikacija: | JOURNAL OF CLINICAL ONCOLOGY | ISSN: | 0732-183X e1527-7755 Journal of Clinical Oncology Pretraži identifikator |
Izdavač: | Lippincott Williams & Wilkins | Tip rezultata: | Konferencijski rad | Kolacija: | vol. 34 br. 15 Suppl. S (Meeting Abstract 3536) | DOI: | 10.1200/JCO.2016.34.15_suppl.3536 | WoS-ID: | 000404665404253 | URI: | https://enauka.gov.rs/handle/123456789/820294 | URL: | https://ascopubs.org/doi/abs/10.1200/JCO.2016.34.15_suppl.3536 | Izvor metapodataka: | (Preuzeto iz Nasi u WoS) | M-kategorija: | Mp kategorija će biti prikazana naknadno. |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.